Loading provider…
Loading provider…
Hematology & Oncology Physician in Rockford, IL
NPI: 1093783250Primary Employer
Javon Bea Hospital Rockton
mercyhealthsystem.org
HQ Phone
Get MD Thomas's Phone Numberphone_androidMobile
Get MD Thomas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 17 | 17 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 11 | 11 |
Authors: Vaishalee Kenkre, Howard Bailey, Wayne Bottner, Brad Kahl, Jules Blank
Journal: Leuk Lymphoma
A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas.
Authors: Mohammed Milhem, Ricardo Costa, Keith Skubitz, Steven Robinson, Scott Okuno, Mark Agulnik
Journal: Ann Oncol
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma.
Authors: Mark Albertini, Heather Neuman, Sharon Weber
Publication Date: 2018-05-10
Lead Sponsor: Northwestern University
Collaborators: National Cancer Institute (NCI), GlaxoSmithKline
Intervention / Treatment: DRUG: Pazopanib Hydrochloride, OTHER: Laboratory Biomarker Analysis, DRUG: Oral Topotecan Hydrochloride
Lead Sponsor: Washington University School of Medicine
Collaborators: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Pazopanib
Lead Sponsor: Northwestern University
Collaborators: National Cancer Institute (NCI), Bayer
Intervention / Treatment: DRUG: regorafenib